Saturday 17 October 2026 Export AQST’s income statement to Excel — free account

Aquestive Therapeutics, Inc.

AQST Healthcare Drug Manufacturers Specialty & Generic

Aquestive Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.5 million, down 22.6% from fiscal 2024. In the quarter to June 2026, revenue grew 38.2%, EPS fell 28.6%, free cash flow fell 20.4% and total debt rose 59.1%, each against the same quarter a year earlier.

3.78 0.28 −6.90%

Follow AQST

Alert me

Market cap: $509.6M
P/E: 0.0×
Fwd P/E: −9.7×
Dividend yield: —
F-score: 2/9
Altman Z: −2.19
Beneish M: −1.91
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	2	2	4
ROE Full definition →		278.54%	178.61%	145.10%	121.12%
ROA Full definition →		(50.44%)	(63.99%)	(56.63%)	(69.29%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(53.05%)	(79.38%)	(67.38%)	(73.82%)
Average Days of Receivables Full definition →		99.25	145.55	49.86	62.94
Free Cash Flow per Share Full definition →		(0.46)	(0.50)	(0.36)	(0.37)
Free Cash Flow Full definition →		(50.94)	(52.99)	(44.32)	(45.95)
Capital Expenditures Full definition →		(0.49)	(0.56)	(0.48)	(0.58)
Other line items
Cash ROIC Full definition →		(32.89%)	(46.07%)	(43.54%)	(49.64%)
Accounts Receivable Turnover Full definition →		4.04	3.55	5.81	5.11
Accounts Payable Turnover Full definition →		1.87	0.92	1.52	1.70
Inventory Turnover Full definition →		2.31	3.04	2.41	2.30
Average Days of Payables Full definition →		230.04	587.42	236.20	183.54
Days of Inventory on Hand Full definition →		166.93	121.35	160.25	150.81
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		43.58%	38.59%	31.90%	29.38%
Selling, General and Administrative Expense of Revenue Full definition →		145.25%	179.25%	142.73%	135.17%
Share Based Compensation of Revenue Full definition →		19.93%	17.12%	16.62%	17.32%
Interest Coverage Full definition →		(3.27)	(4.15)	(3.34)	(3.23)
Operating CF/Net income Full definition →		0.73	0.63	0.64	0.58
Depreciation/Fixed assets Full definition →		2.94	2.97	2.88	2.54
Capex/Depreciation Full definition →		(0.04)	(0.05)	(0.04)	(0.06)
Revenue per Share Full definition →		0.39	0.42	0.41	0.43
Operating CF per Share Full definition →		(0.46)	(0.49)	(0.36)	(0.36)
Capex per Share Full definition →		0.00	(0.01)	0.00	0.00
Capex to Sales Full definition →		0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates

Stockrow Weekly